Bioceramics for regenerative medicine
3-D printing of bioceramics
Cell-materials interaction and co-cultures
Antibacterial bioceramics for smart prosthetic applications
Sponsored by Acers
Nanomedicine and ceramics for cancer
Drug delivery systems
Hybrid ceramics for osteochondral regeneration
Commemorative Session – Bioceramic and glass technology
Innovative processes for 3d bioceramics
Bioceramics for dental applications
Ceramics in skin care and soft tissues applications
Nanosafety applied to bioceramics
Click below to consult the Final Program
PLENARY RELAY SESSIONS
For the first time, we have conceived this session involving clinicians and material scientists on the same podium. Here, highly reputed clinicians will describe relevant clinical needs in the field of, Cranial reconstruction, Osteochondral diseases, Traumatology and Spinal fusion, and will pass the baton to material scientists to discuss about effective approaches and promising solutions.
WORKSHOPS and ROUND TABLES
Organized by companies and EC-funded projects.
Particularly, we will host:
- a workshop focusing on Bioceramics in Neurosurgery
- a workshop held by the EC funded project AIMed, focused on Antimicrobial Integrated Methodologies
- a workshop on Nanosafety, dealing with Safe and Sustainable by Design Paradigms applied to (Nano) materials.
Will be dedicated to aspects critical in the translation of bioceramics to clinics and market such as: Regulatory Aspects & Certification, and Tech Transfer: overcoming the “Valley of Death”.
RESEARCH IDEAS FOR THE MARKET
Competition of Innovative ideas in the field of ceramics for medicine, and related issues on biotechnology and biomedicine. This Competition aims to encourage talent Young Researchers towards “research ideas at the frontiers of Knowledge” and/or to identify collaborative routes with business and local communities on innovative projects dealing with materials for medicine.
CONFIRMED PLENARY SPEAKERS
CONFIRMED KEYNOTE SPEAKERS
University of Ioannina, Greece
Fraunhofer Institute for Ceramic Technologies and Systems, Germany
Polytechnic University of Bucharest, Romania
Universitat International de Catalunya, Spain
Rizzoli Orthopedic Institute, Italy
Indian Institute of Technology, Bangalore, India
RMS Foundation, Switzerland
Chiara Vitale Brovarone
Polytechnic University of Turin, Italy
University of Rome Niccolò Cusano, Italy
Shanghai Institute of Ceramics, China
University of Nantes, France
Tatiana da Ros
University of Trieste, Italy
University of Toulouse, France
University of Pennsylvania, USA
University of North Carolina, USA
Polytechnic University of Milan, Italy
Polytechnic University of Catalunya, Spain
Rizzoli Orthopedic Institute, Italy
Imperial College, UK
University of Tokyo, Japan
Philipps University, Marburg, Germany
Humanitas Research Institute, Italy
Universitè Polytechnique Hauts-de-France, France
Radboud University Medical Center, The Netherlands
National Taiwan University, Taiwan
Riga Technical University, Latvia
University of North Carolina, USA
Polytechnic of Turin, Italy
University Ca’ Foscari, Italy
President of the European Society for Ceramic Implantology, Switzerland
University of Parma, Italy
Prof. Aldo R. Boccaccini
BIOGRAPHY > Aldo R. Boccaccini is Professor of Biomaterials and Head of the Institute of Biomaterials at University of Erlangen-Nuremberg, Germany. He is also Visiting Professor at Imperial College London. His research activities are in the broad area of glasses, ceramics and composites for biomedical applications. He has pioneered the use of bioactive composite scaffolds incorporating bioactive glasses for tissue engineering. Boccaccini has co-authored more than 850 scientific papers. His work has been cited more than 36,000 times (Scopus®). He was included in the “Highly Cited Researchers” list (Clarivate Analytics) in 2018. Boccaccini is Fellow of four international organizations: the Institute of Materials, Minerals and Mining, the American Ceramic Society, the Society of Glass Technology and the European Ceramic Society. He is the Editor-in-Chief of the journal “Materials Letters” and founding Editor and Editor-in-Chief of the Open Access journal “Biomedical Glasses”. Boccaccini has received numerous international awards, including the Materials Science Prize of German Materials Society and Turner Award of International Commission on Glass. He is also a member of the World Academy of Ceramics, and the National Academy of Engineering and Applied Sciences of Germany. A native from Argentina, Boccaccini is an advisor to Argentina’s Science and Technology Ministry. He serves also in the Executive Committee of the Federation of European Materials Societies (since 2016) and in the Council of the European Society for Biomaterials (since 2015).
Prof. Jerome Chevalier
BIOGRAPHY > Born in 1970, Jérôme Chevalier is currently full Professor at the National Institute of Applied Sciences, in Lyon (INSA-Lyon), France. After receiving his PhD in 1996 (Mechanical properties of biomedical grade zirconia), Jérôme Chevalier first became Ceramic Engineer in Saint Gobain Group. In 1997, he joined the National Institute of Applied Sciences, in Villeurbanne and became full Professor in 2004. Jérôme Chevalier is mainly recognized for his work on ceramics for healthcare applications, especially on zirconia as a biomaterial and on the development of innovative glass-ceramics and calcium phosphate ceramics for bone substitute applications. His research interests are also related to the mechanical behaviour laws of ceramics under different forms. He has been involved in a large number of European projects and has coordinated recently the LONGLIFE project. He shows a strong involvement in partnerships with European companies. He has published more than 200 papers, holds 10 patents and has been cited more than 10000 times. Jérôme Chevalier has been member of the ‘Institut Universitaire de France’ (2010-2015) and awarded by the French CNRS with the ‘Innovation Medal’ in 2015. Jérôme Chevalier is currently one of the editors of the Journal of the European Ceramic Society and fellow of the European Ceramic Society (2017). He is member of the World Academy of Ceramics (2018).
Prof. Bengt Fadeel
BIOGRAPHY > Bengt Fadeel is Professor of Medical Inflammation Research at the Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, and Adjunct Professor of Occupational Medicine at the University of Rome Tor Vergata. He obtained his M.D. and Ph.D. from Karolinska Institutet. He served as Vice Chairman of the Institute of Environmental Medicine from 2009-2013 and is Head of the Division of Molecular Toxicology since 2009. Dr. Fadeel was elected as a Fellow of the Academy of Toxicological Sciences in 2012 (recertified in 2018). He is a current or past member or coordinator of several EU-funded projects on nanosafety, including NANOMMUNE, MARINA, NANOREG, SUN, NANOSOLUTIONS, and BIORIMA, as well as member of the Flagship Project GRAPHENE. He is chair of the expert panel and member of the steering group of the national nanosafety platform, SweNanoSafe (since 2016), and chief editor of the nanotoxicology specialty section of Frontiers in Toxicology (since 2019).
Prof. Peter Giannoudis
BSc, MB, MD, FACS, FRCS (Glasg), FRCS (Eng)
- B.Sc. (Sports Medicine), Simon Fraser University, Vancouver, Canada, 1985
- MB, University of Ioannina, Greece, 1990
- Final Board Orthopaedic Surgery, 1997
- CST certificate for training in Orthopaedic & Trauma Surgery (October 1997)
- M.D. (doctorate by thesis) University of Leeds, 2000
- FRCS (Fellow Royal College of Surgeons of England)
- FRCS (Fellow Royal College of Surgeons of Glasgow) FACS (Fellow American College of Surgeons)
- Professor & Chairman Department of Trauma & Orthopaedic Surgery (School of Medicine, University of Leeds)
- Honorary Consultant at Leeds General Infirmary University Hospital (2000 bed teaching hospital, serving a population in the region of 3.5 million)
- Clinical Director Leeds Teaching Hospitals (June 2003- August 2007)
- President of British Trauma Society (January 2003-December 2006)
- President of British Trauma Society (January 2008-January 2009)
- President of the European Society of Pelvis and Acetabulum (2008-2012)
- Executive Board Member of British Orthopaedic Association (BOA) National Trauma committee (active)
- Board Member of NCEPOD committee (active)
- Instructor American Academy Orthopaedic Surgeons (active)
- Instructor British Orthopaedic Association (active)
- Chair International Membership Committee OTA (2012-2019)
- Chairman AO Masters Course (2003-2006)
- Chairman AO Polytrauma course 2009-2010, 2012, 2014
- Executive member EFORT Trauma Task Force (active)
- Secretary ESTROT society (2014-2018)
- President ESTROT society (2018-20120) British Orthopaedic Association Trustee (2018-2021)
- Editor in Chief Injury Journal (2009 onwards)
- Has been awarded since 1997 36 successful grant applications in the sum of over £12 million.
- Published over 650 peer review publications and 12 Orthopaedic and Trauma textbooks.
- Written 80 chapters in Renowned Textbooks of Orthopaedics and Trauma.
- H-index is 95 with 36,615 citations – google scholar (https://scholar.google.com/citations?hl=en&user=xgEn_28AAAAJ)
INVITED KEYNOTE LECTURER / GUEST LECTURER
- Professor Giannoudis is a regular international keynote speaker having delivered over 400 lectures around the world since 2005.
- Visiting Professor at:
University of Louisville, Kentucky, USA; University of Harvard, Boston, USA; University of Leuven, Belgium; University of Pittsburgh, USA; University of Melbourne, Australia; University of Princess of Wales, Newcastle, Australia; University of Aachen, Germany; University of Milan, Italy; University of Macmaster, Hamilton, Canada; National University of Singapore; University of Zurich, Switzerland; University of Charite, Berlin Germany; University of McGill, Montreal, Canada; Aristotelion University of Thessaloniki, Thessaloniki, Greece, University of Ioannina, Ioannina, Greece; Beijing Jishuitan Hospital, Beijing, China.
- Trained over 200 fellows from around the world in Leeds since 2000.
- Teaching instructor of the American Academy of Orthopaedic Surgeons, British Orthopaedic Association, European Federations of Orthopaedics and Traumatology and Chairman of the AO fracture fixation courses.
- For the clinical, research and charity work, Professor Giannoudis has received a number of awards including:
1. Awarded 1st prize of a newly edited book (Practical Procedures in Orthopaedic Trauma Surgery 1st ed) by the Royal Society of Medicine- 10 November 2007, London, UK
2. Ceremonial honorary membership award- German Orthopaedic and Trauma Society DKOU – 23 October 2008, Berlin Germany.
3. Gold Metal of Clinical Excellence, National University of Singapore, 15 November 2008, Singapore.
4. Bronze Clinical Excellence Award-Ministry of Health, UK-17 December 2008, London, UK
5. Ceremonial honorary membership award-Spanish Orthopaedic Society (SECOT) -2 October 2013, Barcelona, Spain.
6. Ceremonial honorary membership award – Czech Trauma and Orthopaedic Society-1 October 2015, Brno, Czechia.
7. Ceremonial honorary membership award- Italian Society of Orthopaedics and Traumatology (SIOT) -15 October 2015, Rome, Italy.
8. Un-sung hero award of National Health System UK (voted by public of Leeds)-24 November 2015, Yorkshire, UK.
9. Highly Commended Medical Book Award (Practical Procedures in Orthopaedic Trauma Surgery 2nd ed)-British Medical Association -15 December 2015, London, UK.
10. Ceremonial honorary membership award- Argentinian Society of Orthopaedics and Traumatology (AAOT) – 3 December 2017, Buenos Ayres, Argentina.
11. Silver Clinical Excellence Award-Ministry of Health, UK-15 September 2017, London, UK.
- Founder of DAY ONE Trauma Charity 1 September 2014.
Prof. Stefano Manfredini
BIOGRAPHY > Stefano Manfredini is professor of pharmaceutical chemistry and toxicology, Director of the School of Pharmacy and Health Products, Director of the Master Course in Cosmetic Science and Technology at the University of Ferrara, Italy. Has a special interest in degenerative processes associated with UV induced oxidative stress. He is particularly dedicated to natural products and their applications in formulation for pharmaceutical, nutritional and cosmetic products. He has solid experience in the extraction, synthesis and characterization of natural products and technology transfer from University to companies. He holds a variety of administrative and teaching posts at the University of Ferrara. He is also the co-founder, with Silvia Vertuani, and President of the university spin-off company, Ambrosialab (www.ambrosialab.it).
Prof. Maurilio Marcacci
Full Professor at Humanitas University Milan
Director of the Centro per la ricostruzione funzionale e biologica del ginocchio, Humanitas Research Hospital, Milan (ITA).
In the past 35 years his carrier and professionalism has been the pillars of the prestigious Istituto Ortopedico Rizzoli of Bologna, where he was Head of the:
- 1st Clinic Orthopaedic and Traumatology
- Complex Units Department
- Laboratory of Biomechanics and Technological Innovation
- Temporary Scientific Director of the Rizzoli Orthopaedic Institute
ACADEMIC BACKGROUND AND EDUCATION
Marcacci graduated summa cum laude in Medicine and Surgery at the University of Pisa and obtained the qualification for the exercise of the medical profession in 1972.
In 1978, he obtained the qualification for the exercise of the medical profession in the USA.
From 1975 to 1985, he specialized in Physical Therapy, Sports Medicine, Orthopedics and Traumatology.
He started teaching at the University of Bologna in 1986, became associate professor at the University of Bologna in 1999, full professor in 2001.
At the University of Bologna Prof Marcacci has been Coordinator of the degree course in Orthopaedic Techniques since 2012, Director of the First Level Master in Biomechanics Diseases, Pathology and treatments of the upper limbs; Director of the School of Specialization in Orthopaedics and Traumatology (2013-2016);
Marcacci holds 9 patents and is head of applied research projects dedicated to sports traumatology, regenerative medicine and innovative techniques for joints reconstruction, the study of new application for stem cells and Platelet-Rich Plasma, biomechanics of the lower limbs with special focus toward new prosthesis implants, and RSA radiography technology.
Marcacci is author of over 400 papers published on international magazines, 48 book chapters, 6 books.
Total H Index according to Google Scholar is: 61
Total references on Google Scholar: 14901
He has been at more than 400 scientific meeting, both national and international, as lecturer and moderator.
He is member of the Editorial Board of the Journal of Sports Traumatology, Technique Knee Surgery, Sphere Medical Journal, Journal of Sport Traumatology, European Journal of Sports Traumatology.
1. R. Quarto, M. Mastrogiacomo, R. Cancedda, SM. Kutepov, V. Mukhachev, A. Lavroukov, E. Kon, M. Marcacci.
“Repair of large bone defects with the use of autologous bone marrow stromal cells”.
New Eng. Journal of Medicine, N. 344 Vol. 5, 385-6, Feb 2001.
2. E. Kon, A. Gobbi, G. Filardo, M. Delcogliano, S. Zaffagnini, M. Marcacci.
“Arthroscopic Second Generation Autologous Chondrocyte Implantation compared with Microfracture for chondral lesions of the Knee. Prospective non randomized study at 5 years”.
AM J SPORT Med 2009 Jan;37(1):33-41.
3. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, Fornasari PM, Giannini S, Marcacci M.
“Platelet-Rich Plasma Intra-Articular Injection Versus Hyaluronic Acid Viscosupplementation as Treatments for Cartilage Pathology: From Early Degeneration to Osteoarthritis”.
Arthroscopy. 2011 Nov;27(11):1490-501.
4. Kon E, Vannini F, Buda R, Filardo G, Cavallo M, Ruffilli A, Nanni M, Di Martino A, Marcacci M, Giannini S.
“How to Treat Osteochondritis Dissecans of the Knee: Surgical Techniques and New Trends: AAOS Exhibit Selection”.
J Bone Joint Surg Am. 2012 Jan 4;94(1):e11-8.
5. Iacono F, Raspugli GF, Filardo G, Bruni D, Zaffagnini S, Bignozzi S, Lo
Presti M, Akkawi I, Neri MP, Marcacci M. The adductor tubercle: an important landmark to determine the joint line level in revision total knee arthroplasty.
Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3212-3217
ACADEMIC HONORS, AWARDS AND PRICES
- 2016 award for the “most cited publication 2011-2016” and “most downloaded publication 2011-2016”, for the paper: “Platelet-Rich Plasma Intra-articular Injection Versus Hyaluronic Acid Viscosupplementation as Treatments for Cartilage Pathology: from Early Degeneration to Osteoarthritis”, published by Arthroscopy The Journal of Arthroscopic and Related Surgery in 2011.
- 2016 award for “one of the most highly cited papers during 2014-2015”, for the paper: “Scaffold-based repair for cartilage healing: A systematic review and technical note”, published by Arthroscopy: The Journal of Arthroscopic and Related Surgery, in 2013.
- Award Cum Laude for the publication of the digital poster ““Platelet-Rich Plasma Intra-articular Injection Versus Viscosupplementation for Treatments of Degenerative Knee Pathology: A randomized controlled trial”, showed at the ICRS World Congress, Chicago, USA, 2015.
- 2013 award for “ten top-cited articles published in the Arthroscopy Journal 2011-2012”, for the paper: “Platelet-Rich Plasma Intra-articular Injection Versus Hyaluronic Acid Viscosupplementation as Treatments for Cartilage Pathology: from Early Degeneration to Osteoarthritis”, published by Arthroscopy: The Journal of Arthroscopic and Related Surgery, in 2011.
- Leading article Knee Surgery Sports Traumatology Arthroscopy Journal: “Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics”, 2013.
- Award Cum Laude for the publication of the digital poster “Should we still talk about patellofemoral cartilage lesions? A comparative study”, showed at the 11° ICRS World Congress, Izmir, Turchia, 2013.
- Award for the “most cited pubblication 2009-2010” for the paper: “Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years” published by the American Journal of Sports Medicine in 2009
- Best medical presentation at ORTOMED Meeting 2012.
- Scientific exhibit award of excellence AAOS 2011 Annual Meeting: “How to treat Osteochondritis Dissecans of the Knee: Surgical Techniques and new trends”.
Franco Servadei, MD
- Graduated in Medicine University of Bologna, 1976, Cum Laude
- Full Training in Neurosurgery 1985
- EANS Training Certificate , 1985
- Experience of work abroad: Sweden (Stocholm) , UK (Sheffield , Edinburgh)
- Staff Neurosurgeon at Bellaria Hospital Bologna (1985-1990)
- Director of Neurotrauma and Emergency Care, Dept. Bufalini Hospital Cesena (1990-2007),
- Director of Neurosurgery-Neurotraumatology , University Hospitals of Parma and Reggio Emilia, Italy (2007-2016)
- Full Professor of Neurosurgery , Humanitas University , Milano, Italy, 2017-today
- Honorary Professor of Neurosurgery Burdenko Institute, Moskow, Russia
- Honorary Professor of Neurosurgery, Universita’ Italiana di Buenos Aires , Argentina
- Honorary Professor of Neurosurgery, University of Surabaya, Indonesia
- Honorary Visiting Professor of neurosurgery, University of Cambridge, UK
- Chairman the Neurotrauma Committee of the WFNS (2002-2009)
- President Italian Neurosurgical Society 2010-2012
- President Elect, WFNS (2015) and President , the World Federation of Neurosurgical Societies 2017-2021
- Immediate Past president WFNS 2021-today
- Invited speaker in the last 10 years to 72 international meetings in all the 5 Continents of the WFNS
- Visiting professor in UK, Taiwan, Russia, Argentina, India, Indonesia, USA, Brazil, Vietnam, France, Bolivia
- Chairman of 5 international training course for young Neurosurgeons, teacher in other 17 Courses
- Organizer of 5 International World Meetings
- H Index 46, 266 documents , 9141 citations from 6667 documents as per 15 december 2021
- 5 book chapter, 3 journals issues as Chief Editor
- In last 5 years: 20 papers on head injuries, 13 papers on brain tumors , 9 papers on spine and other topics , 10 papers on Global Neurosurgery
Prof. Yasuhiko Tabata
BIOGRAPHY > Dr. Yasuhiko Tabata is the Professor and Chairman of the Laboratory of Biomaterials at the Institute for Frontier Life and Medical Sciences, Kyoto University and a Professor of the Graduate School of Medicine, Osaka University, and guest professors at the Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, and Engineering of 17 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He was a Visiting Scientist at the MIT (Professor Robert Langer) (1991-92). He has published 1,630 scientific papers including 145 book chapters and review articles, and has 130 patents. He received the Young Investigator Award (1990), the Scientific Award from the Japanese Society for Biomaterials (2002), the Scientific Award from the Japan Society of Drug Delivery System (2011), Chandra P. Sharma Award of the International Society of Biomaterials & Artificial Organs (2011), the Scientific Award from the Japanese Society for Regenerative Medicine (2014), Merit Award Winners for Industry-Academia-Government Collaboration, President of Science Council of Japan Award (2016), Outstanding Scientist Award of TERMIS-AP (2018), and several awards.
Dr. Tabata is the board member of the Japanese Society of Regenerative Medicine (JSRM), the Japanese Society for Biomaterials (JSB), the Japan Society of Drug Delivery System (JSDDS), and the Japanese Society of Inflammation and Regeneration (JSIR) or the councilor of the Japanese Society of Wound Healing, the Japanese Artificial Organ Society, He is an associate member of the Science Council of Japan, Cabinet Office, a fellow of the New York Academy of Science and American Institute for Medical and Biological Engineering (AIMBE), and the Founding Fellow for Tissue Engineering and Regenerative Medicine, (FTERM).
Dr Tabata is the one of founder members of Asian Biomaterial Federation (ABF). He is a board member of Tissue Engineering Society International for 2001-2003 and 2012-present. He organized as the chairman the 13th Annual Congress of JSRM (2014) and the 37th Annual Congress of JSB (2015), the 37th Annual Congress of JSIR (2016), and the 33th Annual Congress of JSDD (2017). He is a board member of TERMIS-AP for 2013-present and the president of TERMIS-AP for 2016-2020, and chairs the 5th TERMIS World Congress 2018, Kyoto, Japan.
His research is very interdisciplinary in nature and brings together the fields of polymer chemistry, pharmaceutical science, biology, and basic and clinical medicines. He actively proceeds translational researches by linking bioengineering scientists, clinicians, and industry to achieve clinical therapies of regenerative medicine as well as produce some commercialization products for basic researches and cosmetics. His research focuses on the design and preparation of biodegradable or non-biodegradable biomaterials for their biological, medical, and pharmaceutical applications, while the keywords are biomaterials, drug delivery system (DDS), tissue engineering, regenerative medicine, stem cell technology, and medical diagnostics.
Prof.ssa Livia Visai
BIOGRAPHY > Livia Visai is an Associate Professor in Biochemistry at the Department of Molecular Medicine (DMM), Faculty of Medicine and referent for the academic strategic project “Center for Health Technology (CHT)” of the University of Pavia; Visai is also research collaborator in quality of Associate Professor at the Scientific Clinical Institutes (ICS) Maugeri, IRCCS of Pavia. Visai has been Member of the Scientific Committee of the Foundation of the European Centre for Nanomedicine (CEN) until this year. Since 2018, She has a ISTEC-CNR Associate position. Visai is also Member of the Scientific Committee of the Italian Society for Biomaterials (SIB). Her scientific research activity takes place mainly in the field of nanotechnology applications for the reduction of infection and of bacterial biofilm, for the diagnosis and treatment of tumors (breast cancer), and in the field of tissue engineering/reparative medicine. Visai has obtained various funding, including the grant by the Italian Space Agency (ASI) after a public selection for the project “Nanoparticles and osteoporosis (NATO)” which was part of the “Futura Mission” of the Italian Captain and Astronaut Samantha Cristoforetti on the International Space Station (ISS) in 2015. She has published over 160 articles by peer review process (PubMed) and 7-deposited patents.
Prof.ssa Hala Zreiqat
BIOGRAPHY > Hala Zreiqat AM is a Professor of Biomedical Engineering at the University of Sydney; a National Health and Medical Research Council Senior Research Fellow; Co-Director of the Shanghai-Sydney Joint Bioengineering and Regenerative Medicine Lab at Shanghai JiaoTong; Honorary Professor Shanghai Jiao Tong University and Adjunct Professor Drexel University. Her research is on the development of novel engineered materials and 3D-printed platforms that mimic tissue structures, particularly in orthopaedic, dental, and maxillofacial applications. She has received national and international awards. She pioneers national and international technology development, and has received national and international awards, including the Order of Australia; the 2018 New South Wales Premier’s Woman of the Year; The King Abdullah II Order of Distinction of the Second Class – the highest civilian honour bestowed by the King of Jordan (2018); Eureka Prize winner for Innovative Use of Technology (2019); Fellow of the Australian Academy of Health and Medical Sciences (2019); Fellow of International Orthopaedic Research (FIOR); and University of Sydney Payne-Scott Professorial Distinction (2019).
Her research is on the development of novel engineered materials and 3D-printed platforms that mimic tissue structures, particularly in orthopaedic, dental, and maxillofacial applications. Her group is also developing the technology for effective biological approaches through biochemical and cellular modification for the repair and regenerating of large bone defects and non-union bone fractures.
She has established national and international industry collaborations to translate her discoveries into approved medical devices. Her pioneering development of innovative biomaterials for tissue regeneration has led to one awarded (US) and 8 provisional patents, and several collaborations with inter/national industry partners. She has been awarded more than $18 M in competitive funding including from the NHMRC, ARC and the NSW Medical Devices Fund. She is the past president of the Australian & New Zealand Orthopaedic Research Society; founder and Chair of the Alliance for Design and Application in Tissue Engineering (ADATE) (2006-present); founder of IDEAL Society (Inclusion, Diversity, Equity, Action Leadership) at Harvard University (2017-); member of the National Health and Medical Research Senior Research grant review panel, the Australian Research Council Expert College and German Research Foundation. Prof. Zreiqat’s overall objective is to advance collaborative research ventures and build educational and industry linkages nationally and internationally in the field of musculoskeletal disorders and biomaterials research.